Advertisement
Screener

Cellectar Biosciences, Inc. (CLRB) Acquisitions, Net of Cash Acquired

2.8 / 5 stars · 68/120 Roast Me

Cellectar Biosciences, Inc. Acquisitions, Net of Cash Acquired

Cellectar Biosciences, Inc. (CLRB) reported Acquisitions, Net of Cash Acquired of $905.65 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2013-03-28.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2013-03-28

  • Cellectar Biosciences, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2011-03-31 was $905.65K.
  • Cellectar Biosciences, Inc. payments to acquire businesses, net of cash acquired for fiscal 2011 was $905.65K.
Period endPayments to Acquire Businesses, Net of Cash Acquired 3 monthPayments to Acquire Businesses, Net of Cash Acquired 12 month
2011-12-31$905.65K
10-K · filed 2013-03-28
2011-03-31$905.65K
10-Q · filed 2012-11-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
Marker Therapeutics, Inc. (MRKR)United States$0.020B-2.86
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Rocket One Inc. (RKTO)United States$0.019B
ATOSSA THERAPEUTICS, INC. (ATOS)United States$0.021B-0.52
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Lipocine Inc. (LPCN)United States$0.017B-1.79
Cocrystal Pharma, Inc. (COCP)United States$0.022B
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66